Hypertrophic Cardiomyopathy: Collaborating for a Cure video

Hypertrophic Cardiomyopathy (HCM), a heritable cardiac disease affecting 1 in 500 people, is the most important cause of sudden death in young adults and athletes. Cardiologists have made tremendous advances in the diagnosis and treatment of human HCM, and these advances have made their way into veterinary medicine, where they have helped cats. Pet cats also develop HCM but at a much higher rate, affecting 10-15% of cats. While feline patients have been benefiting from advances in human cardiology for many years, the tables are now turning. Hypertrophic cardiomyopathy would provide a highly effective example of the value of One Health for improving both human and animal health.

Also see the accompanying manuscript in Cardiology Research

Woman running with dog

Chronic Pain in Companion Animals video

Chronic pain is a common issue in both companion animals and humans. Pets and humans frequently suffer from similar pain-causing conditions such as bone cancer, diabetes, interstitial cystitis, and osteoarthritis.

Experts on both sides of the One Health spectrum demonstrate how transdisciplinary collaboration, leveraging the stronger validity of naturally occurring disease models, could lead to improved pain control in humans through optimized translational approaches.

Clinical trials in pet dogs and cats to evaluate innovative new drugs or treatments can benefit both animals and humans. Naturally-occurring painful disease in companion animals offers unparalleled opportunities for physicians and veterinarians to collaborate to develop better treatments for all of their patients.